Matcons wrote: JohnnCash wrote: I bought right before the big plunge for twice the price but I have no one to blame but myself. Down 40%!!!!. Very jealous of anyone that got in under $2 let alone the <$1 range. Very optimistic nonetheless. GLTA
This will make you feel better Johnny my boy!
On January 2, Namaste and Aurora Cannabis Inc. (“Aurora”) announced the signing of a binding term sheet towards a final Private-Label Software Agreement ("Private Label Agreement"), whereby Namaste will provide Aurora's wholly-owned subsidiary, CanvasRx Inc. ("CanvasRx") with a customized version of Namaste's patient acquisition tool, NamasteMD.com ("NamasteMD"), as well as desktop and mobile applications for Google Android and Apple iOS platforms. The companies have 30 days to complete a final agreement. Private Label Agreement NamasteMD is an online telemedicine platform for patient consultation and registration, bringing together Namaste`s tested technology platform, including certain proprietary authentication technologies, as well as consultation, education and medical document issuance processes. Under the terms of the Private Label Agreement:
• Namaste will provide CanvasRx with a customized, CanvasRxbranded version of NamasteMD.
• Namaste will provide CanvasRx with a two-year exclusivity period for the private label version of NamsteMD.com in Canada.
• Namaste will initially provide the application for both the Google Android and Apple iOS platforms.
• CanvasRx will require their own doctors and/or nurse practitioners to operate the platform. • Commercial terms of the agreement are not disclosed.
• In consideration of Aurora's assistance for the future optimization of NamasteMD, Namaste has issued Aurora 500,000 stock options, exercisable
at $3.35 per common share for 48 months, vesting quarterly over 12 months Support Services Agreement In addition, the companies have also signed a non-binding, non-exclusive Letter of Intent to complete a final Consultation & Support Services Agreement ("Consultation Agreement"), whereby Namaste will provide patient referral services to Aurora, where applicable under Canada's Access to Cannabis for Medical Purposes ("ACMPR") regulations. Under the terms of the Consultation Agreement: